Instil Bio (TIL) Short term Debt (2020 - 2023)
Instil Bio (TIL) posted quarterly Short term Debt of $120000.0 for Q2 2023, down 52.38% year-over-year from $252000.0 in Q2 2022, and down 2.44% quarter-over-quarter from $123000.0 in Q1 2023.
Instil Bio (TIL) Short term Debt (2020 - 2023) Analysis & Trends
Instil Bio's Short term Debt history runs 4 years deep, the most recent figure standing at $120000.0 for Q2 2023.
- In Q2 2023, Short term Debt fell 52.38% year-over-year to $120000.0; the TTM figure through Jun 2023 stood at $120000.0 (down 52.38% YoY), while the FY2022 annual figure was $360000.0, down 73.15% from the prior year.
- Short term Debt for Q2 2023 stood at $120000.0, down from $123000.0 in the prior quarter.
- The five-year high for Short term Debt was $2.1 million in Q2 2021, with the low at $120000.0 in Q2 2023.
- The 4-year median for Short term Debt is $867000.0 (2022), against an average of $899909.1.
- The sharpest annual moves came in 2021 and 2022: Short term Debt declined 3.11% in 2021, then sank 88.02% in 2022.
- Instil Bio's Short term Debt stood at $1.4 million in 2020, then decreased by 3.11% to $1.3 million in 2021, then sank by 73.15% to $360000.0 in 2022, then slumped by 66.67% to $120000.0 in 2023.
- Business Quant data shows TIL's Short term Debt at $120000.0 in Q2 2023, $123000.0 in Q1 2023, and $360000.0 in Q4 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Instil Bio | 51.68 Mn | 51.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 120,000.00 |
| Mar 31, 2023 | 123,000.00 |
| Dec 31, 2022 | 360,000.00 |
| Sep 30, 2022 | 412,000.00 |
| Jun 30, 2022 | 252,000.00 |
| Mar 31, 2022 | 867,000.00 |
| Dec 31, 2021 | 1.34 Mn |
| Sep 30, 2021 | 1.53 Mn |
| Jun 30, 2021 | 2.10 Mn |
| Mar 31, 2021 | 1.41 Mn |
| Dec 31, 2020 | 1.38 Mn |